Current Hematologic Malignancy Reports

Papers
(The H4-Index of Current Hematologic Malignancy Reports is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions165
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations36
Targeting RUNX1 Germline Variants: Agents Under Investigation27
Monoclonal Gammopathy-Associated Neuropathy26
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease25
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations22
Management of Chronic Myeloid Leukemia in Children and Young Adults22
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities20
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer19
Value in Myeloma Care: Myth or Reality19
Splicing Factor Mutations in Chronic Myelomonocytic Leukemia: Biological Consequences and Therapeutic Implications19
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications19
Allogeneic Transplant for CMML18
Transplantation and Cellular Therapy for Older Adults—The MSK Approach18
Prognostic and Predictive Models in Myelofibrosis16
How Do We Manage Chronic Lymphocytic Leukemia in India15
0.045109987258911